Changes
On July 25, 2022 at 10:02:22 AM UTC,
![francis](https://dms.hiv.health.gov.mw/uploads/user/2022-05-09-190700.480236DSC5202-1.jpg)
-
No fields were updated. See the metadata diff for more details.
f | 1 | { | f | 1 | { |
2 | "author": "", | 2 | "author": "", | ||
3 | "author_email": "cmkandawire@hivmw.org", | 3 | "author_email": "cmkandawire@hivmw.org", | ||
4 | "creator_user_id": "c64e3919-2d1c-42bf-835b-e85a6be9792c", | 4 | "creator_user_id": "c64e3919-2d1c-42bf-835b-e85a6be9792c", | ||
5 | "groups": [], | 5 | "groups": [], | ||
6 | "id": "ddae8e3e-64a7-4eda-ac70-311be890bd48", | 6 | "id": "ddae8e3e-64a7-4eda-ac70-311be890bd48", | ||
7 | "isopen": false, | 7 | "isopen": false, | ||
8 | "license_id": "notspecified", | 8 | "license_id": "notspecified", | ||
9 | "license_title": "License not specified", | 9 | "license_title": "License not specified", | ||
10 | "maintainer": null, | 10 | "maintainer": null, | ||
11 | "maintainer_email": null, | 11 | "maintainer_email": null, | ||
12 | "metadata_created": "2022-07-25T10:01:20.807306", | 12 | "metadata_created": "2022-07-25T10:01:20.807306", | ||
n | 13 | "metadata_modified": "2022-07-25T10:02:22.278909", | n | 13 | "metadata_modified": "2022-07-25T10:02:22.467019", |
14 | "name": "malawi-integrated-hiv-program-report-2019-q2", | 14 | "name": "malawi-integrated-hiv-program-report-2019-q2", | ||
15 | "notes": "* Scale-up of integrated HIV services had reached the | 15 | "notes": "* Scale-up of integrated HIV services had reached the | ||
16 | following number of sites:\r\n * __759__ static and __139__ | 16 | following number of sites:\r\n * __759__ static and __139__ | ||
17 | outreach HIV testing sites\r\n * __749__ (static) ART sites; | 17 | outreach HIV testing sites\r\n * __749__ (static) ART sites; | ||
18 | __616__ of these started at least one pregnant or breastfeeding woman | 18 | __616__ of these started at least one pregnant or breastfeeding woman | ||
19 | and __720__ started asymptomatic patients (Test & Treat) this | 19 | and __720__ started asymptomatic patients (Test & Treat) this | ||
20 | quarter\r\n * __691__ sites with HIV-exposed children in follow-up | 20 | quarter\r\n * __691__ sites with HIV-exposed children in follow-up | ||
21 | \r\n* __1,007,296__ persons were tested for HIV and received their | 21 | \r\n* __1,007,296__ persons were tested for HIV and received their | ||
22 | results; __207,831 (21%)__ accessed HIV testing for the first time; | 22 | results; __207,831 (21%)__ accessed HIV testing for the first time; | ||
23 | __799,465 (79%)__ were repeat testers and __33,613 (3%)__ of these | 23 | __799,465 (79%)__ were repeat testers and __33,613 (3%)__ of these | ||
24 | received confirmatory testing (after having tested positive in the | 24 | received confirmatory testing (after having tested positive in the | ||
25 | past). __28,912 (2.8%)__ clients received a positive result for the | 25 | past). __28,912 (2.8%)__ clients received a positive result for the | ||
26 | first time1.\r\n* __19,675 (98%)__ of 20,078 blood units collected | 26 | first time1.\r\n* __19,675 (98%)__ of 20,078 blood units collected | ||
27 | were screened for (at least) HIV, hepatitis B and syphilis\r\n* | 27 | were screened for (at least) HIV, hepatitis B and syphilis\r\n* | ||
28 | __160,860 (97%)__ of 165,689 women at ANC had their HIV status | 28 | __160,860 (97%)__ of 165,689 women at ANC had their HIV status | ||
29 | ascertained; __10,830 (7%)__ of these were HIV positive. __134,297 | 29 | ascertained; __10,830 (7%)__ of these were HIV positive. __134,297 | ||
30 | (94%)__ of 142,538 at maternity had their HIV status ascertained | 30 | (94%)__ of 142,538 at maternity had their HIV status ascertained | ||
31 | __9,845 (7%)__ of these were HIV positive.\r\n* __28,318__ patients | 31 | __9,845 (7%)__ of these were HIV positive.\r\n* __28,318__ patients | ||
32 | started ART this quarter; __67%__ were classified as asymptomatic / in | 32 | started ART this quarter; __67%__ were classified as asymptomatic / in | ||
33 | WHO stage 1 and started under the \u201cTest & Treat\u201d | 33 | WHO stage 1 and started under the \u201cTest & Treat\u201d | ||
34 | policy.\r\n* __819,947__ patients were alive and on ART by end of June | 34 | policy.\r\n* __819,947__ patients were alive and on ART by end of June | ||
35 | 2019. This means that __78%__ of the estimated 1,066,811 HIV positive | 35 | 2019. This means that __78%__ of the estimated 1,066,811 HIV positive | ||
36 | population was on ART. ART coverage was __68%__ (46,754/ 68,727) for | 36 | population was on ART. ART coverage was __68%__ (46,754/ 68,727) for | ||
37 | children and __78%__ (781,570 / 998,084) for adults.\r\n* __104,156 | 37 | children and __78%__ (781,570 / 998,084) for adults.\r\n* __104,156 | ||
38 | (92%)__ of viral load results from routine monitoring were <1000 | 38 | (92%)__ of viral load results from routine monitoring were <1000 | ||
39 | copies/ml. Viral suppression rates for routine samples among children | 39 | copies/ml. Viral suppression rates for routine samples among children | ||
40 | (0-14 years) and adults (15+ years) were __65%__ and __93%__, | 40 | (0-14 years) and adults (15+ years) were __65%__ and __93%__, | ||
41 | respectively.\r\n* __70%__ of adults and __76%__ of children were | 41 | respectively.\r\n* __70%__ of adults and __76%__ of children were | ||
42 | retained alive on ART at 12 months after initiation.\r\n* Out of | 42 | retained alive on ART at 12 months after initiation.\r\n* Out of | ||
43 | __791,146__ patients on first line adult ART __323,124 (42%)__ were on | 43 | __791,146__ patients on first line adult ART __323,124 (42%)__ were on | ||
44 | TDF/3TC/EFV and __422,245 (55%)__ had transitioned to | 44 | TDF/3TC/EFV and __422,245 (55%)__ had transitioned to | ||
45 | TDF/3TC/DTG.\r\n* __11,765 5 (>99%)__ of an estimated 10,932 2 HIV | 45 | TDF/3TC/DTG.\r\n* __11,765 5 (>99%)__ of an estimated 10,932 2 HIV | ||
46 | infected pregnant women in Malawi were on ART this quarter. __8,461 | 46 | infected pregnant women in Malawi were on ART this quarter. __8,461 | ||
47 | (72%)__ of these were already on ART when getting pregnant and __3,303 | 47 | (72%)__ of these were already on ART when getting pregnant and __3,303 | ||
48 | (28%)__ started ART during pregnancy/delivery.\r\n* An additional | 48 | (28%)__ started ART during pregnancy/delivery.\r\n* An additional | ||
49 | __1,160__ breastfeeding women started ART in WHO stage 1 or 2.\r\n* | 49 | __1,160__ breastfeeding women started ART in WHO stage 1 or 2.\r\n* | ||
50 | __78%__, and __70%__ of women started while pregnant or breastfeeding | 50 | __78%__, and __70%__ of women started while pregnant or breastfeeding | ||
51 | were retained on ART at 6 and 12 months after initiation, | 51 | were retained on ART at 6 and 12 months after initiation, | ||
52 | respectively.\r\n* __9,037 (7%)__ of infants discharged alive from | 52 | respectively.\r\n* __9,037 (7%)__ of infants discharged alive from | ||
53 | maternity were known to be HIV exposed, __8,456 (94%)__ of these | 53 | maternity were known to be HIV exposed, __8,456 (94%)__ of these | ||
54 | received ARV prophylaxis (nevirapine).\r\n", | 54 | received ARV prophylaxis (nevirapine).\r\n", | ||
55 | "num_resources": 1, | 55 | "num_resources": 1, | ||
56 | "num_tags": 8, | 56 | "num_tags": 8, | ||
57 | "organization": { | 57 | "organization": { | ||
58 | "approval_status": "approved", | 58 | "approval_status": "approved", | ||
59 | "created": "2021-10-14T11:02:35.234558", | 59 | "created": "2021-10-14T11:02:35.234558", | ||
60 | "description": "The Department of HIV & AIDS (DHA) was established | 60 | "description": "The Department of HIV & AIDS (DHA) was established | ||
61 | in 2001, initially as a unit in the Department of Clinical Services, | 61 | in 2001, initially as a unit in the Department of Clinical Services, | ||
62 | to coordinate the biomedical HIV Program in Malawi. The department now | 62 | to coordinate the biomedical HIV Program in Malawi. The department now | ||
63 | carries responsibility for various HIV related programs including: | 63 | carries responsibility for various HIV related programs including: | ||
64 | sexually transmitted infections (STIs), prevention of mother to child | 64 | sexually transmitted infections (STIs), prevention of mother to child | ||
65 | transmission of HIV (PMTCT), and national voluntary male medical | 65 | transmission of HIV (PMTCT), and national voluntary male medical | ||
66 | circumcision program (VMMC). All these HIV program sub-sections are | 66 | circumcision program (VMMC). All these HIV program sub-sections are | ||
67 | linked to one robust monitoring and evaluation sub-section in the HIV | 67 | linked to one robust monitoring and evaluation sub-section in the HIV | ||
68 | and AIDS Department which technically operates under the Central | 68 | and AIDS Department which technically operates under the Central | ||
69 | Monitoring and Evaluation Department (CMED) of the Ministry of | 69 | Monitoring and Evaluation Department (CMED) of the Ministry of | ||
70 | Health.", | 70 | Health.", | ||
71 | "id": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | 71 | "id": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | ||
72 | "image_url": | 72 | "image_url": | ||
73 | 2022-04-18-074318.527302WhatsApp-Image-2022-04-18-at-9.42.07-AM.jpeg", | 73 | 2022-04-18-074318.527302WhatsApp-Image-2022-04-18-at-9.42.07-AM.jpeg", | ||
74 | "is_organization": true, | 74 | "is_organization": true, | ||
75 | "name": "dha", | 75 | "name": "dha", | ||
76 | "state": "active", | 76 | "state": "active", | ||
77 | "title": "Department of HIV & AIDS and Viral Hepatitis", | 77 | "title": "Department of HIV & AIDS and Viral Hepatitis", | ||
78 | "type": "organization" | 78 | "type": "organization" | ||
79 | }, | 79 | }, | ||
80 | "owner_org": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | 80 | "owner_org": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | ||
81 | "private": false, | 81 | "private": false, | ||
82 | "program_area": "Care and Treatment", | 82 | "program_area": "Care and Treatment", | ||
83 | "relationships_as_object": [], | 83 | "relationships_as_object": [], | ||
84 | "relationships_as_subject": [], | 84 | "relationships_as_subject": [], | ||
85 | "resources": [ | 85 | "resources": [ | ||
86 | { | 86 | { | ||
87 | "cache_last_updated": null, | 87 | "cache_last_updated": null, | ||
88 | "cache_url": null, | 88 | "cache_url": null, | ||
89 | "created": "2022-07-25T10:02:22.304864", | 89 | "created": "2022-07-25T10:02:22.304864", | ||
90 | "description": "Integrated HIV Program Report April-June 2019", | 90 | "description": "Integrated HIV Program Report April-June 2019", | ||
91 | "format": "PDF", | 91 | "format": "PDF", | ||
92 | "hash": "", | 92 | "hash": "", | ||
93 | "id": "b33b9d7f-9966-47d3-81fb-cc074080162c", | 93 | "id": "b33b9d7f-9966-47d3-81fb-cc074080162c", | ||
94 | "last_modified": "2022-07-25T10:02:22.196334", | 94 | "last_modified": "2022-07-25T10:02:22.196334", | ||
95 | "lfs_prefix": | 95 | "lfs_prefix": | ||
96 | "dha/malawi-integrated-hiv-program-report-2019-q2", | 96 | "dha/malawi-integrated-hiv-program-report-2019-q2", | ||
n | 97 | "metadata_modified": "2022-07-25T10:02:22.285705", | n | 97 | "metadata_modified": "2022-07-25T10:02:22.470806", |
98 | "mimetype": "application/pdf", | 98 | "mimetype": "application/pdf", | ||
99 | "mimetype_inner": null, | 99 | "mimetype_inner": null, | ||
100 | "name": "Malawi Integrated HIV Program Report 2019 Q2", | 100 | "name": "Malawi Integrated HIV Program Report 2019 Q2", | ||
101 | "package_id": "ddae8e3e-64a7-4eda-ac70-311be890bd48", | 101 | "package_id": "ddae8e3e-64a7-4eda-ac70-311be890bd48", | ||
102 | "position": 0, | 102 | "position": 0, | ||
103 | "resource_type": null, | 103 | "resource_type": null, | ||
104 | "sha256": | 104 | "sha256": | ||
105 | "d487eab63f2c51c263cb7970450eb60415dae81bf55b72bf83baa7cecb97c41b", | 105 | "d487eab63f2c51c263cb7970450eb60415dae81bf55b72bf83baa7cecb97c41b", | ||
106 | "size": 4472339, | 106 | "size": 4472339, | ||
107 | "state": "active", | 107 | "state": "active", | ||
108 | "url": | 108 | "url": | ||
109 | 074080162c/download/malawi_integrated_hiv_program_report_2019-q2.pdf", | 109 | 074080162c/download/malawi_integrated_hiv_program_report_2019-q2.pdf", | ||
110 | "url_type": "upload" | 110 | "url_type": "upload" | ||
111 | } | 111 | } | ||
112 | ], | 112 | ], | ||
t | 113 | "state": "draft", | t | 113 | "state": "active", |
114 | "tags": [ | 114 | "tags": [ | ||
115 | { | 115 | { | ||
116 | "display_name": "art", | 116 | "display_name": "art", | ||
117 | "id": "ab255b9d-6d35-4789-8ce0-ce10bbe1e299", | 117 | "id": "ab255b9d-6d35-4789-8ce0-ce10bbe1e299", | ||
118 | "name": "art", | 118 | "name": "art", | ||
119 | "state": "active", | 119 | "state": "active", | ||
120 | "vocabulary_id": null | 120 | "vocabulary_id": null | ||
121 | }, | 121 | }, | ||
122 | { | 122 | { | ||
123 | "display_name": "blood safety", | 123 | "display_name": "blood safety", | ||
124 | "id": "24fd7907-18be-4ad1-80ad-ba65da6a9707", | 124 | "id": "24fd7907-18be-4ad1-80ad-ba65da6a9707", | ||
125 | "name": "blood safety", | 125 | "name": "blood safety", | ||
126 | "state": "active", | 126 | "state": "active", | ||
127 | "vocabulary_id": null | 127 | "vocabulary_id": null | ||
128 | }, | 128 | }, | ||
129 | { | 129 | { | ||
130 | "display_name": "hiv", | 130 | "display_name": "hiv", | ||
131 | "id": "43013fde-ebf4-470e-9e5d-1a3aa939d404", | 131 | "id": "43013fde-ebf4-470e-9e5d-1a3aa939d404", | ||
132 | "name": "hiv", | 132 | "name": "hiv", | ||
133 | "state": "active", | 133 | "state": "active", | ||
134 | "vocabulary_id": null | 134 | "vocabulary_id": null | ||
135 | }, | 135 | }, | ||
136 | { | 136 | { | ||
137 | "display_name": "maternity", | 137 | "display_name": "maternity", | ||
138 | "id": "cd2b6dc5-5d1f-4a03-91da-9a279e193ed2", | 138 | "id": "cd2b6dc5-5d1f-4a03-91da-9a279e193ed2", | ||
139 | "name": "maternity", | 139 | "name": "maternity", | ||
140 | "state": "active", | 140 | "state": "active", | ||
141 | "vocabulary_id": null | 141 | "vocabulary_id": null | ||
142 | }, | 142 | }, | ||
143 | { | 143 | { | ||
144 | "display_name": "pmtct", | 144 | "display_name": "pmtct", | ||
145 | "id": "06c11980-f1fe-470d-8791-aeee38a117d5", | 145 | "id": "06c11980-f1fe-470d-8791-aeee38a117d5", | ||
146 | "name": "pmtct", | 146 | "name": "pmtct", | ||
147 | "state": "active", | 147 | "state": "active", | ||
148 | "vocabulary_id": null | 148 | "vocabulary_id": null | ||
149 | }, | 149 | }, | ||
150 | { | 150 | { | ||
151 | "display_name": "report", | 151 | "display_name": "report", | ||
152 | "id": "80c23033-8ff3-483d-8aa6-03e39b117372", | 152 | "id": "80c23033-8ff3-483d-8aa6-03e39b117372", | ||
153 | "name": "report", | 153 | "name": "report", | ||
154 | "state": "active", | 154 | "state": "active", | ||
155 | "vocabulary_id": null | 155 | "vocabulary_id": null | ||
156 | }, | 156 | }, | ||
157 | { | 157 | { | ||
158 | "display_name": "sti", | 158 | "display_name": "sti", | ||
159 | "id": "38222aa3-73ca-4ca8-8b42-9a5eb558af5a", | 159 | "id": "38222aa3-73ca-4ca8-8b42-9a5eb558af5a", | ||
160 | "name": "sti", | 160 | "name": "sti", | ||
161 | "state": "active", | 161 | "state": "active", | ||
162 | "vocabulary_id": null | 162 | "vocabulary_id": null | ||
163 | }, | 163 | }, | ||
164 | { | 164 | { | ||
165 | "display_name": "viral load", | 165 | "display_name": "viral load", | ||
166 | "id": "e385a0a4-1722-431f-a657-f9616a14bf6f", | 166 | "id": "e385a0a4-1722-431f-a657-f9616a14bf6f", | ||
167 | "name": "viral load", | 167 | "name": "viral load", | ||
168 | "state": "active", | 168 | "state": "active", | ||
169 | "vocabulary_id": null | 169 | "vocabulary_id": null | ||
170 | } | 170 | } | ||
171 | ], | 171 | ], | ||
172 | "title": "Malawi Integrated HIV Program Report 2019 Q2", | 172 | "title": "Malawi Integrated HIV Program Report 2019 Q2", | ||
173 | "type": "dataset", | 173 | "type": "dataset", | ||
174 | "url": null, | 174 | "url": null, | ||
175 | "version": null, | 175 | "version": null, | ||
176 | "year": "2019" | 176 | "year": "2019" | ||
177 | } | 177 | } |